Panel Discussion & Extended Q&A
- Explore how the Swiss Cheese Model applies to layered EHS defences in biopharma, from engineering controls to human behaviour and management systems
- Identify where new “holes” are emerging as modalities evolve and operations grow more complex, from potent compounds to digital workflows
- In what ways can human factors, digital monitoring, and behavioural data be used to close the “holes” between procedural intent and real-world practice?